Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Monthly Archives: March 2012
University researchers to test new community pharmacy service
Posted: Published on March 27th, 2012
Public release date: 27-Mar-2012 [ | E-mail | Share ] Contact: Emma Rayner emma.rayner@nottingham.ac.uk 44-077-382-91242 University of Nottingham A new NHS community pharmacy scheme to help patients understand and get the best out of a new medicine is to be tested and evaluated by a team led by The University of Nottingham in collaboration with University College London and Warwick Business School. The New Medicine Service started in October 2011 and will run until March 2013 with funding of up to 55 million in both 2011/12 and 2012/13 available for its delivery. The service provides support from community pharmacists for people with long-term conditions who are newly prescribed a medicine to help them solve any problems with their medication or its management. The study is being led by Professor Rachel Elliott and Dr Matthew Boyd. Dr Boyd said: "The New Medicine Service is a great opportunity to formalise the excellent work community pharmacists already do every day supporting patients with their medicines. This study intends to provide an evidence base for how pharmacists can support patients with their new medicines. It is hoped it will inform the development of more pharmacy services in the future." Professor Nick Barber from the … Continue reading
Posted in Pharmacy
Comments Off on University researchers to test new community pharmacy service
Burman’s Specialty Pharmacy Collaborates with Connexus Technology to Architect Data Management and Portal Tool
Posted: Published on March 27th, 2012
Connexus Technology, a trusted innovator of data management tools for the healthcare industry, collaborated with Burmans Specialty Pharmacy to develop a sophisticated software solution to accelerate their specialty pharmacy business. The software, along with a user friendly patient portal has been designed to better administer the clinical management of patient care and streamline internal reporting processes. Existing data management tools were not providing us with the capabilities beyond gap analysis to improve our patient clinical care. We took it upon ourselves to build a customized solution that integrates our systems, while streamlining our monthly reporting processes, said John Regester, COO, Burmans Specialty Pharmacy. The investment in this software and the collaboration with Connexus enables us to be clinically superior and is one of our biggest advantages in 2012. Burmans vision was to develop software that could act as a one-stop shop and enable the pharmacy to offer better patient care. The company identified the need for this software to elevate their patient management capabilities including secure sharing of lab results, meeting insurance requirements and ongoing patient monitoring. This level of clinical management requires software that provides greater insight and visibility between the pharmacy operating system, patient and provider. Connexus provided … Continue reading
Posted in Pharmacy
Comments Off on Burman’s Specialty Pharmacy Collaborates with Connexus Technology to Architect Data Management and Portal Tool
Autism Care Provider Wellspring Goes Out of Business
Posted: Published on March 27th, 2012
NORTH HILLS, Calif. (KTLA) -- A series of Southern California treatment centers for children with autism closed Friday without warning, leaving the parents of the young patients wondering what happened. Wellspring Health Care and Home Care provided treatment for thousands of children with autism across Southern California until Friday, when its locations shut their doors, apparently for good. Some employees told KTLA they haven't been paid for a month. Others said they received an email last week informing them they wouldn't be paid Friday. Caroline Simha -- the mother of a child with autism -- wonders what she will do now that Wellspring is no longer open. "When the services are cut, it's like you don't know where to go," she told KTLA. Wellspring founder and CEO Leo Landeverde issued the email to his employees last week saying they wouldn't be paid due to "cash flow problems." That same day, Landeverde tweeted, "Can you start over after losing it all? A man of God can." His Twitter bio changed from Wellspring CEO to Passionate Christ Follower, Entrepreneur, Missionary Coaching. Financial Freedom Fighter, Inspiring People to overcome. All Odds God's Way." "There's obviously something wrong when somebody shuts their doors so … Continue reading
Comments Off on Autism Care Provider Wellspring Goes Out of Business
Judge: Florida Medicaid Must Cover Therapy for Autism
Posted: Published on March 27th, 2012
Published: Tuesday, March 27, 2012 at 2:18 a.m. Last Modified: Tuesday, March 27, 2012 at 2:18 a.m. LAKELAND | Florida's Medicaid program must cover applied behavioral analysis for children who are diagnosed with autism and related disorders, a federal judge in Miami ruled Monday morning. An estimated 8,500 Florida children on Medicaid are identified now as having full-blown autism or related conditions falling under the umbrella of autism spectrum disorder. The decision will benefit them, along with other children diagnosed with those disorders in the future who need behavioral health therapy. U.S. District Court Judge Joan Lenard called the state's decision not to cover ABA therapy "arbitrary, capricious and unreasonable, both in its process and in its conclusion." The Florida Agency for Health Care Administration didn't follow its standard process for determining whether a treatment or service should be covered when it ruled against applied behavioral analysis. It didn't apply the state's definition of experimental and failed to use "reliable evidence" as defined by Florida law, Lenard said in the permanent injunction order against the state agency. The agency has a month in which to appeal the injunction if it chooses to do so. "We're so excited about the decision," … Continue reading
Comments Off on Judge: Florida Medicaid Must Cover Therapy for Autism
Cynapsus Therapeutics Reports 2011 Financial Results and Highlights Key Developments
Posted: Published on March 27th, 2012
TORONTO, ONTARIO--(Marketwire - March 26, 2012) - Cynapsus Therapeutics Inc. (TSX VENTURE:CTH.V - News), a specialty pharmaceutical company developing an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease, today announced its results for the fourth quarter and fiscal year ended December 31, 2011. Unless specified otherwise, all amounts are in Canadian dollars. "2011 was a successful year for Cynapsus with achievement of multiple significant milestones. In particular, the year was highlighted by the completion of the first human clinical trial for APL-130277, the announcement of findings from a global neurologist survey confirming market need for APL-130277, and the completion of the acquisition of Adagio Pharmaceuticals," said Anthony Giovinazzo, President and Chief Executive Officer of Cynapsus. "Building on this success, we remain focused on the completion of a dose escalation study in the next 3 to 4 months, as well as preparations for an Investigational New Drug Application to the US FDA for a clinical BioEquivalence study later in the year. The BEQ study is the next critical de-risking milestone that we believe will drive significant shareholder value." Financial Highlights Operational Highlights The following achievements were made during the year: Cynapsus Completed the First … Continue reading
Posted in Parkinson's Treatment
Comments Off on Cynapsus Therapeutics Reports 2011 Financial Results and Highlights Key Developments
Evie thinks she just has 'wobbly legs'. The truth will break your heart
Posted: Published on March 27th, 2012
By Lucy Elkins PUBLISHED: 17:56 EST, 26 March 2012 UPDATED: 23:39 EST, 26 March 2012 Like all children, five-year-old Evie Read likes to talk about what shes going to do when she grows up, specifically what she will do when I am a mummy and when I can drive a car. Its the sort of thing that would provoke a smile in most parents, but for Emily and Toby Read it is simply heartbreaking for they know that without a medical miracle, their beautiful daughter will not get to experience any of these things. Watching Evie bouncing off the sofa during a boisterous game of doctors and nurses with her three-year-old brother Wilf, its hard to envisage her as anything other than a healthy, active little girl. Toby and Emily Read with (from left) Evie, Wilf and Albie. Evie has ataxia-telangiectasia, a genetic disorder. How long she has before she loses her physical abilities, no one knows Indeed, until very recently there were no obvious warning signs that anything was wrong. Evie achieved the usual development targets and was advanced in her talking. She said her first word duck at ten months. She didnt even have much in the way … Continue reading
Comments Off on Evie thinks she just has 'wobbly legs'. The truth will break your heart
Midlands Vet Uses Stem Cell Therapy for Pets in Pain
Posted: Published on March 27th, 2012
Columbia, SC (WLTX) --What if your pet couldn't walk anymore? One Midlands vet is using stem cell therapy to help. For Beth Phibbs it's almost like a turning back of the hands of time. "I call her my little miracle dog, because she's doing things she used to do," said Phibbs. "Now she's not on any medication, and she can go up and down the steps and she runs and jumps and things that she used to do when she was five." Phibbs has spent the last 13 years loving and looking after her pet dog Maggie, and when she pet began to develop arthritis and a limp she had to take action. But when the first treatments stopped working, Phibbs and Maggie had to look to another options, dog stem cell therapy. "I had no idea that animals were able to have they type of procedures," she said. Dr. Kenneth Banks a veterinarian with the Bank Animal Hospital, performed the surgery for Maggie using her own stem cells in the one day procedure. Banks said the stem cell therapy not only cost less than some other options, but was less invasive and had a quicker recovery time as well. … Continue reading
Comments Off on Midlands Vet Uses Stem Cell Therapy for Pets in Pain
AABB releases new guidelines for red blood cell transfusion
Posted: Published on March 27th, 2012
Public release date: 26-Mar-2012 [ | E-mail | Share ] Contact: Angela Collom acollom@acponline.org 215-351-2653 American College of Physicians Philadelphia, March 27, 2012 AABB (formerly known as the American Association of Blood Banks) recommends a restrictive red blood cell transfusion strategy for stable adults and children, according to new guidelines being published in Annals of Internal Medicine. Physicians should consider transfusing at a hemoglobin threshold of 7 to 8 g/dL, as the evidence shows no difference in mortality, ability to walk independently, or length of hospital stay between patients on a liberal transfusion strategy or a restrictive strategy. Wide variability in the use of transfusions in the United States indicates that in many settings patients are receiving unnecessary transfusions. Our recommendation is based on the evidence that restrictive transfusion is safe and associated with less blood use, said Jeffrey L. Carson, MD, Chief of the Division of General Internal Medicine at UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, and lead author of the guideline. Of course, clinical judgment is critical. Physicians may choose to transfuse above or below the specified hemoglobin threshold based on individual patient characteristics. A 20-member panel of experts based their assessment on a systematic review … Continue reading
Posted in Cell Medicine
Comments Off on AABB releases new guidelines for red blood cell transfusion
Vatican Calls Off Stem-Cell Conference
Posted: Published on March 27th, 2012
Nature | Health A Monsignor and Officer for Studies at the Pontifical Academy for Life called the cancellation a "sad event." Attendees are set to receive an official explanation March 26, 2012| By Ewen Callaway of Nature magazine The Vatican has abruptly cancelled a controversial stem-cell conference that was set to be attended by the Pope next month. The Third International Congress on Responsible Stem Cell Research, scheduled for 25-28 April, was to focus on clinical applications of adult and reprogrammed stem cells. But a number of the invited speakers, including Alan Trounson, president of the California Institute for Regenerative Medicine in San Francisco, and keynote speaker George Daley, a stem-cell scientist at Children's Hospital Boston in Massachusetts, are involved in research using human embryonic stem cells, which the Catholic Church considers unethical. The previous two congresses had also included scientists who worked on such cells, without generating much controversy. Father Scott Borgman, secretary of the Church's Pontifical Academy for Life, one of the conference organizers, says that logistical, organizational and financial factors forced the cancellation, which was announced on 23 March. The academy weighs in on bioethical and theological issues that are relevant to Church teachings. The Catholic News … Continue reading
Posted in Cell Medicine
Comments Off on Vatican Calls Off Stem-Cell Conference
University of Washington’s Neuro-Oncology Program to Investigate Cell Therapeutics’ Drug Candidate OPAXIO™ (Paclitaxel …
Posted: Published on March 27th, 2012
SEATTLE, March 27, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced that the University of Washington's ("UW") School of Medicine, Departments of Neurology and Neurosurgery, Division of Neuro-Oncology has begun enrolling patients in a randomized phase II clinical study comparing the combination of OPAXIO (paclitaxel poliglumex, PPX, CT-2103) and radiation therapy ("RT") to the combination of temozolomide ("TMZ") and RT for patients with newly-diagnosed glioblastoma multiforme ("GBM"), which is a poor-prognosis high-grade malignant brain tumor with an active gene called MGMT. MGMT is active in more than half of patients with glioblastoma and it substantially decreases the effectiveness of standard therapy with TMZ. This study is a multicenter trial initiated and led by the Neuro-Oncology department of the Brown University Oncology Research Group ("BrUOG") in Providence, Rhode Island. The first patient at UW recently has been enrolled. Dr. Maciej Mrugala, Associate Professor of Neurology, Neurological Surgery and Medicine at UW's School Of Medicine and Affiliate Investigator at Fred Hutchinson Cancer Research Center is leading the study at the UW site. "Patients with glioblastomas are rarely cured, although current standard therapy with RT and TMZ has been shown to prolong survival. A Phase I/II study of paclitaxel … Continue reading
Posted in Cell Medicine
Comments Off on University of Washington’s Neuro-Oncology Program to Investigate Cell Therapeutics’ Drug Candidate OPAXIO™ (Paclitaxel …